Related Experiment Videos
[Allergic bronchopulmonary aspergillosis (ABPA)]
1Department of Respiratory Diseases, International Medical Center of Japan, Tokyo, Japan.
Kekkaku : [Tuberculosis]
|February 1, 1997
Summary
Allergic bronchopulmonary aspergillosis (ABPA) encompasses a broader range of lung diseases than previously defined. Diagnosis requires considering allergic reactions, HRCT findings, and disease staging for effective management.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Infectious Diseases
Background:
- Allergic pulmonary aspergillosis (ABPA) is a complex lung condition involving allergic reactions and destructive inflammation caused by Aspergillus.
- Current diagnostic criteria for ABPA, established in 1977, may not fully encompass the disease's spectrum.
Observation:
- This study reviews 11 cases of ABPA, proposing an expanded definition.
- Key diagnostic indicators include allergic responses to Aspergillus and characteristic findings on chest HRCT, such as central bronchiectasis and mucus plugging.
Findings:
- The proposed expanded entity of ABPA includes various stages, cases without asthma, and complications with chronic bacterial infections.
- Progression to infectious and invasive aspergillosis is a potential concern.
Implications:
- Management strategies should differentiate between acute and chronic stages.
- Systemic steroids are crucial for acute ABPA; bronchial toileting aids mucus removal.
- Antifungal and inhaled steroid therapies may be necessary for chronic or recurrent cases to prevent lung injury.